Left atrial size after cardioversion for atrial fibrillation: effect of external DC shock by Mattioli, Anna Vittoria et al.
Left Atrial Size After Cardioversion for Atrial
Fibrillation: Effect of External Direct
Current Shock
Anna Vittoria Mattioli, MD, Silvia Bonatti, MD, Lorenzo Bonetti, MD, and
Giorgio Mattioli, MD, Modena and Reggio Emilia, Italy
Objective. The aim of this study was to evaluate the
effect of external direct current (DC) shock on left
atrial (LA) dimension and volumes after cardiover-
sion for atrial fibrillation, and the relation be-
tween LA size and atrial function.
Methods. We evaluated 180 patients who were ran-
domly cardioverted with DC shock (90 patients) or
drugs (90 patients). Echocardiographic evaluations
included LA size and volumes. LA passive and active
emptying volumes were calculated, and LA function
was measured as atrial ejection force. Changes in LA
diameters and volumes were correlate with atrial
systolic function.
Results. The LA was dilated in all patients during
arrhythmia and decreased after the restoration of
sinus rhythm. The entity of reduction was different
in the 2 groups of patients. LA maximal and minimal
volumes were increased after DC shock as compared
with patients treated with drugs (LA maximal volume
34 4 vs 31 5; P < .01; LA minimal volume 18 2.6
vs 15  3.6; P < .01). The atrial function was also
depressed after DC shock and the delay in the recov-
ery of atrial contractility was related to LA dilation.
Patients treated with drugs had a higher atrial ejec-
tion force that was associated with a more marked re-
duction in LA maximal volume after the restoration
of in sinus rhythm. A relationship between LA vol-
umes and atrial ejection force was observed in the
group of patients with depressed atrial mechanic
function (r  0.78; P < .001). The active emptying
fraction was lower, although not significantly, in this
group, whereas the conduit volume was increased.
Conclusion. External DC shock induced a depressed
atrial mechanic function in many patients and this
was associated with a persistence of LA dilation.
(J Am Soc Echocardiogr 2003;16:271-6.)
The relationship between left atrial (LA) size and
atrial fibrillation (AFib) is controversial. It is well
known that AFib causes atrial dilation, and progres-
sive LA enlargement occurs once AFib becomes
chronic.1,2 Conversely, dilatation may partially regress
if in sinus rhythm is restored.3 The Stroke Prevention
in Atrial Fibrillation (SPAF) study showed that multiple
factors contribute to LA enlargement, including the
presence and persistence of the arrhythmia.4 The
Framingham study showed a relation between LA size
and the risk of stroke in men, and the risk of death
in both sexes.5,6 This study evaluates the changes in




Patients who were hemodynamically stable and referred
for cardioversion for nonrheumatic AFib were considered
for inclusion in this study. The study group included 255
consecutive patients with a primary diagnosis of AFib. To
be included, patients needed documentation of the ar-
rhythmia by electrocardiography. The onset of AFib was
defined as “a new and clearly recognizable onset of
symptoms including palpitations, dyspnea, dizziness, or a
combination of such symptoms.” Exclusion criteria were
atrial flutter, recent acute myocardial infarction, reduced
ejection fraction  45%, episodes of heart failure, mitral
and aortic valvular stenosis and prosthesis, more than mild
mitral and aortic insufficiency, atrial and/or left-ventricular
thrombosis, spontaneous echocontrast, and spontaneous
cardioversion of the arrhythmia. We also excluded pa-
tients who were admitted with another diagnosis and
patients who had secondary AFib. Of the initial 255
patients, 75 were excluded because they did not meet the
inclusion criteria. The remaining 180 patients randomly
receive pharmacologic or electric cardioversion. Patients
were classified as group 1 if they underwent external
electric cardioversion (n  90), and group 2 if they were
treated with procainamide hydrochloride or propafenone
hydrochloride (n  90). At the time of enrollment,
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patients were on the following medications for ventricular
rate control: digoxin (n  39 patients; 21.6%) and
propafenone hydrochloride (n  12 patients; 6.6%). No
patients received therapy with specific calcium antago-
nists. All patients were hospitalized because of an acute
episode of AFib, they were treated with anticoagulants
and underwent transesophageal echocardiography then
cardioversion was performed. Patients with echocardio-
graphic risk factors as indicated by SPAF study were
excluded from this study.7 These patients were treated
with anticoagulants for at least 30 days and underwent a
different protocol of cardioversion according to AFib
guidelines.8 The decision to undergo either electric or
chemical cardioversion was left to the referring physician
unaware of the protocol. Clinicians could excluded a
patient from the study on the basis of echocardiography
findings but could not change the modality of cardiover-
sion. Procainamide hydrochloride and propafenone hy-
drochloride were randomly chosen following a blind list.
The protocol was approved by the ethical committee of
our university and all patients signed an informed consent
form with detailed information on the protocol.
Cardioversion
DC shock was performed with the use of anterior paddles
in patients who were fasting and received intravenous
sedation with propofol. A total of 77 patients (85.5%)
cardioverted with a single monophasic electric shock; 2
shocks were required in the other patients. The total
amount of electric energy used for cardioversion was
250 190 J per patient. Pharmacologic cardioversion was
performed using bolus procainamide hydrochloride (56
patients) or propafenone hydrochloride (34 patients).
Procainamide hydrochloride was infused at the dosage of
100 mg intravenously administered every 5 minutes up to
a maximum dose of 1 g. Propafenone hydrochloride was
given at a dose of 2 mg/kg body weight intravenously over
30 minutes. As soon as normal in sinus rhythm was
restored electrocardiogram rhythm strips were obtained.
All patients who were cardioverted were treated with
propafenone hydrochloride after the restoration of in
sinus rhythm.
Echocardiography
A complete M-mode and 2-dimensional color Doppler
echocardiogram was performed on each patient using a
commercial echocardiograph (Hewlett Packard, Andover,
Mass) with a 2.5-MHz probe. A transesophageal study was
also performed before cardioversion in all patients to
investigate the presence of LA thrombi and LA spontane-
ous echocontrast. The following parameters were mea-
sured and compared:
Y LA size was measured during systole along the paraster-
nal long-axis view from 2-dimensionally guided M-mode
tracings.9
Y LA volumes were determined at mitral valve opening
(maximal volume), at onset of atrial systole (P wave of
electrocardiogram, P volume), and at mitral valve clo-
sure (minimal volume). LA volumes were measured
from the apical 4- and 2-chamber views by means of the
biplane area-length method and corrected for body
surface area.10 From the LA volumes the following
parameters were estimated. LA passive emptying was
assessed as: LA passive emptying volume (maximal
volume  P volume), conduit volume (left-ventricular
stroke volume  [maximal volume  minimal vol-
ume]), and LA passive emptying fraction (LA passive
emptying volume/maximal volume). LA active empty-
ing was estimated using: LA active emptying volume (P
volume  minimal volume) and LA active emptying
fraction (LA active emptying volume/P volume). LA
total emptying volume was also calculated: (maximal
volume  minimal volume). Contribution of passive
emptying volume ([maximal volume  P volume]/
stroke volume); conduit volume (conduit volume/
stroke volume); and active emptying volume ([P volume
 minimal volume])/stroke volume) to left-ventricular
stroke volume was also evaluated.11
Y Mitral orifice area was assumed to be circular and
estimated from the mitral annulus diameter as measured
from the apical 4-chamber view.
Y Transmitral pulsed Doppler was recorded from apical
4-chamber view, with the sample volume positioned
between the tips of the mitral leaflets. Peak early filling
(E) and atrial filling (A) velocities were recorded. Decel-
eration time and pressure half time were measured from
the transmitral flow pattern.
Y The atrial ejection force (AEF) (dynes) was evaluated
using the following equation12:
0.5    mitral orifice area  (peak A velocity)2.
The unit force was measured in dynes. The variability
between measurements was previously assessed in our
laboratory.13 Effective mechanic atrial function was de-
fined as “the presence of AEF 7 dynes and of atrial filling
wave peak velocity  0.5 m/s.”12,13 All measurements
were taken during quiet breathing with patients in the left
lateral decubitus position. All Doppler results are the
mean measurements of 5 cardiac cycles. The Doppler
signal was analyzed using an IBM computer (Milan, Italy).
Thirty percent of beats measured for each patient were
checked for accuracy by a second investigator (A.V.M.);
90% correlation was found between the analysts. A com-
plete Doppler echocardiographic examination was per-
formed immediately (1 hour), at day 1, and day 7 after the
restoration of in sinus rhythm. The follow-up was discon-
tinued if the patients reverted to AFib (8 patients after 7
days and 9 after 15 days).
Statistical Analysis
Data are expressed as mean value  1 SD for continuous
variables. The statistical significance of serial changes in
echocardiographic parameters was determined by analysis
of variance for repeated measures. Values for patients of
different groups were compared using the Student un-
paired t test. Because the mean age was not different
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among the groups compared, statistical adjustment was
considered unnecessary. Pearson correlation coefficient
was used to study the correlation between 2 parameters.
A P value  .05 was considered significant.
RESULTS
The mean duration of AFib in the total population
was 64  23 hours. Elective cardioversion for AFib
was accomplished with DC shock in 87 patients
(96.6%; group 1) and pharmacologically in 51 pa-
tients (56.6%; group 2). The mean duration of
arrhythmia was 40  17 hours in group 1 and 44 
21 hours in group 2 (P  not significant). The 2
groups were similar with respect to age and under-
line cardiac diseases (Table 1). Baseline echocardi-
ography showed that LA diameters and volumes
were enlarged in all patients during AFib (Tables 2
and 3). Examinations performed 1 hour after the
restoration of sinus rhythm showed a decrease of LA
diameters and volumes in 36 (70.5%) patients re-
verted with drugs, and in 47 (54%) patients cardio-
verted with DC shock. Serial evaluation of LA diam-
eters and volumes are shown in Tables 2 and 3. The
reduction of anteroposterior diameter was more
marked than the reduction of superoinferior diame-
ter (-7% vs 10% in group 1 and 13.1% vs 17.9%
in group 2). Comparing the 2 groups the reduction
was more evident in group 2 compared with group
1 (Figure 1). Atrial mechanic function was measured
using peak A wave velocity and AEF. The initial
values of the peak A wave velocity and of AEF in
patients who underwent DC shock were signifi-
cantly lower compared with patients in group 2
(peak A wave 38 16 vs 45 20; P .001 and AEF
6  1.6 vs 9  2; P  .001).
Effective atrial mechanic function was considered
if AEF was found to be 7 dynes; in group 1, AEF
was7 dynes in 46 patients (52.8%) compared with
41 patients in group 2 (80.3%; P  .01). An AEF  7
dynes was associated with a more marked reduction
in LA size after the restoration of in sinus rhythm. LA
volumes were greater in patients who showed a
delay in the restoration of atrial mechanic function
and an AEF  7 dynes. This group included a higher
number of patients who underwent DC shock. The
active emptying volume was lower, although not
significantly, in patients with AEF  7 dynes group
(5  2.6 vs 7  2.3; P  .03) whereas the passive
emptying volume was similar to patients with an
AEF  7 dynes (10  2.9 vs 9  3; P  not
significant). The conduit volume was increased in
patients who had an AEF  7 dynes compared with
patients with a normal AEF (30  5.9 vs 28  3.6;
P .05). At day 7 we reported 5 recurrences of AFib
in patients with a reduced atrial function (3 patients
in group 1, and 2 patients in group 2) and 3
recurrences in patients with a normal atrial me-
chanic function (1 patient in group 1, and 2 patients
in group 2). At day 7, 44 patients (93%) who
underwent successful pharmacologic cardioversion
showed a good recovery of atrial mechanic function
whereas in the group of patients who underwent
successful DC shock, 74 patients (98%) showed a
good atrial mechanic function.
Table 4 shows the correlation between LA vol-
umes and diameters and AEF. We found a good
inverse correlation between AEF and LA diameters
in patients with a depressed atrial function (AEF 7
dynes), and the correlation was stronger for the
superoinferior diameter (r  0.76; P  .001)
(Figure 2). LA maximal volume after cardioversion
was also inversely correlated with AEF (r  0.79;
P  .001).
DISCUSSION
This study evaluated the effect of DC shock on LA
volumes and diameter and the relationship between
anatomic changes and atrial mechanic function. The
salient observation from this study is that both LA
size reduction and function are significantly de-
pressed after electric cardioversion. A second obser-
vation was that the duration of AFib was shorter in
patients who accomplished successful cardioversion
independently on the modality. LA diameters and
volumes were measured before and after cardiover-
sion and were found to be reduced after the recov-
ery of in sinus rhythm. Nevertheless, we reported a
different rate of reduction among different patients.
The modality of cardioversion seems to influence
the magnitude of reduction. The reduction of atrial
size was more marked in patients after chemical
compared with electric cardioversion. We observed
that the different modality of cardioversion can also
affect the recovery of atrial mechanic function.






Age (ys) 60  16 61  16
Male/female 67/23 61/29
Height (cm) 169  13 171  9
Weight (kg) 84  20 86  20
Body mass index (kg/m2) 27  3 26  2
Mean ventricular rate (bpm) 94  24 95  26
Systemic hypertension No. patients (%) 14 (15) 15 (16)
Diabetes mellitus No. patients (%) 11 (12) 10 (11)
Coronary artery disease No. patients (%) 4 (4) 3 (3)
Left ventricular EF (%) 51  10 52  9
Systolic blood pressure (mm Hg) 134  22 132  12
Diastolic blood pressure (mm Hg) 90  10 89  11
EF, Ejection fraction.
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Previous reports showed that LA mechanic function
is impaired after cardioversion of AFib, and the
recovery of atrial function is delayed in patients who
undergo DC shock compared with patients who
undergo pharmacologic cardioversion.13,14 This
study showed a correlation between recovery of
atrial function and the size of the LA. The temporal
course of return of atrial contraction velocities to
normal values is associated with a reduction of LA
volumes. The progressive augmentation of AEF,
which occurs during successive intervals, was ac-
companied by a corresponding change in LA vol-
umes in both group of patients. Patients who under-
went DC shock had a slower recovery of atrial
function and of LA volumes reduction, implying a
greater degree of atrial dysfunction. These findings
are in agreement with previous studies.13,15
LA Dilation and AFib
It is controversial as to whether the LA enlargement
in AFib is the result rather than the cause of AFib.
Some investigators showed that AFib contributes to
the enlargement of the atria.2,16 The SPAF study on
LA enlargement demonstrated the relationship be-
Figure 1 Reduction of left-atrial anteroposterior (antero-
post) and superoinferior (supero-inf) diameters after cardio-
version.
Table 2 Changes in left-atrial diameters and volume after electric cardioversion of atrial fibrillation
AFib SR after CV SR after 1 day SR after 7 days
LV end-diastolic diameter (mm) 56  3 54  4 53  3* 52  2.8*
LV end-systolic diameter (mm) 36  3 34  3.2 33  3.1* 33  2.9*
LV end-diastolic volume (cm3) 124  6 123  8 122  5 123  7
LV end-systolic volume (cm3) 66  4 65  7 65  5 65  6
LA size anteroposterior diameter (mm) 44  3 41  3* 40  2.8† 38  3†
LA size superoinferior diameter (mm) 48  2.9 44  4* 43  5† 41  4†
Maximal volume (cm3) 36  6 34  4* 33  6* 32  5†
Minimal volume (cm3) 19  3 18  2.6 15  2.9* 14  2†
Atrial ejection force (dynes)  6  1.6 9  2* 12  3.1†
AFib, Atrial fibrillation; SR, In sinus rhythm; LV, left-ventricular; LA, left-atrial; CV, cardioversion.
*P  .01 versus AFib; †P  .001 versus AFib.
Table 3 Changes in left-atrial diameters and volume after pharmacologic cardioversion of atrial fibrillation
AFib SR after CV SR after 1 day SR after 7 days
LV end-diastolic diameter (mm) 55  4 54  3.8 52  3.1* 52  2.8*
LV end-systolic diameter (mm) 36  4 34  3 33  3.2* 33  3*
LV end-diastolic volume (cm3) 123  5.6 123  6.2 122  5.7 123  6
LV end-systolic volume (cm3) 67  5 67  6.7 65  6 65  6
LA size anteroposterior diameter (mm) 43  2.9 40  3.1* 38  2.6† 38  3†
LA size superoinferior diameter (mm) 46  3 42  4* 40  5† 39  4.3†
Maximal volume (cm3) 36  6 31  5† 30  6† 28  6†
Minimal volume (cm3) 19  4 15  3.6* 12  2.9† 11  2.2†
Atrial ejection force (dynes)  9.2  1.6 12  2* 13  2.8*
AFib, Atrial fibrillation; SR, In sinus rhythm; CV, cardioversion; LV, left-ventricular; LA, left-atrial.
*P  .01 versus AFib; †P  .001 versus AFib.
Table 4 Correlation between echocardiographic








r P r P
LA anteroposterior
diameter
r  0.51 .05 r  0.26 .18
LA superoinferior
diameter
r  0.76 .001 r  0.24 .23
LA maximal volume r  0.79 .001 r  0.44 .03
LA minimal volume r  0.48 .05 r  0.43 .028
LA, left-atrial.
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tween atrial size and AFib. The SPAF study showed
that chronic AFib, long-lasting AFib, and systemic
hypertension were independently associated with a
large LA diameter.4 A recent study from the Mayo
Clinic showed a relationship between LA volume
and outcome event of AFib. LA volume was a
significant and independent predictor of incident
AFib in older patients.17 We reported a shorter
duration of AFib in patients who were successfully
cardioverted. This is the reason why our patients
had just a mild dilation of LA. Nevertheless, this
study suggests a direct relationship between the
delay in the restoration of mechanic atrial function
and a persistently dilated LA. This phenomenon is
more evident after electric cardioversion and might
be related to atrial electric remodeling. In diastole,
the LA acts as a conduit between the pulmonary
veins and the left ventricle, so that LA function is
primarily influenced by the same factors that deter-
mine left-ventricular filling.18 The LA size is closely
related to diastolic filling pressure.17,19 An increase
in left-ventricular end-diastolic pressure causes LA
stretch, which may contribute to the development
of AFib. After cardioversion the LA remain dilated
and vulnerable to AFib triggers. DC shock induced a
delay in the recovery of atrial contraction. Anatomic
changes occurring in the atria during AFib may have
a deleterious effect persistent once sinus rhythm is
restored. Biochemic and histologic changes in LA
myocytes may be associated with anatomic changes
in atrial volumes.20,21 We observed that smaller
increments of LA diameter measured by M-mode
echocardiography are associated with greater
changes of LA volume. After cardioversion of AFib,
the conduit function was enhanced in patients with
a depressed atrial contractility whereas the contri-
bution of the active emptying volume to left-ventric-
ular stroke volume did not vary. The conduit volume
was increased as a result of the increase in early
diastolic filling. LA mechanic function is influenced
by LA preload and afterload.22 No changes in atrial
preload and afterload were observed in patients
after DC shock. We can conclude that the decrease
in atrial myocardial contractility may be the cause of
the decrease in atrial performance. This depressed
atrial contractility could be related to stunning in-
duced by atrial electric remodeling.23
Limitations
The major limitation was that this study was not
randomized. The decision between electric and
chemical conversion was left to the referring physi-
cian. The other limitation was that, as in the usual
clinical study, there is no baseline assessment of LA
size and function in sinus rhythm before the onset of
AFib.
Clinical Implications
DC shock is the most successful approach of cardio-
version but is associated with a prolonged atrial
stunning. The duration of atrial stunning is variable
depending on the duration of preceding AFib and
atrial size. Shorter duration of arrhythmia and small
LA dimension are associated with a less severe
stunning. We report a more prolonged atrial stun-
ning associated with electric cardioversion. This
observation suggests that anticoagulant therapy after
conversion of AFib is mandatory in patients who
have undergone DC shock as a result of the in-
creased embolic risk. Atrial stunning is related to
dilation of atrial chambers. A persistent dilated LA
could be the morphologic change associated with a
reduced atrial systolic function.
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